NCT02703584View on ClinicalTrials.gov

Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation

PHASE4CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Infertility
Interventions
DRUG

Buseralin

OTHER

Placebo

DRUG

pregnyl

Trial Locations (1)

M5G 2K4

TRIO Fertility, Toronto

All Listed Sponsors
lead

Mount Sinai Hospital, Canada

OTHER

NCT02703584 - Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation | Biotech Hunter | Biotech Hunter